Clinical Trial Update: A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic Hyponatremia [Phase 3]

View source ↗

Summary

Phase 3 randomized, double-blind, placebo-controlled trial evaluating the safety and tolerability of oral lixivaptan capsules in adults with euvolemic hyponatre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Euvolemic Hyponatremia

Drugs mentioned

• Lixivaptan (lixivaptan)

Snippet

Sponsor: CardioKine Inc. | Conditions: Euvolemic Hyponatremia | Phase 3 | Status: COMPLETED